To explore the anti-tumor activity of deguelin in vivo, we performed mice xenograft models using WT EGFR and mutant EGFR expressing NSCLC cells, including A549, HCC827, H3255, and H1975 cells. This evidence concerns the gene EGFR and neoplasm.